Literature DB >> 22397723

Multiple myeloma and immunomodulation: regulating the regulatory cells.

Chitta S Kasyapa1, Taimur Sher, Asher A Chanan-Khan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22397723     DOI: 10.3109/10428194.2012.670233

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  Regulatory T cells in allogeneic stem cell transplantation.

Authors:  Maria Michael; Avichai Shimoni; Arnon Nagler
Journal:  Clin Dev Immunol       Date:  2013-05-08

2.  Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.

Authors:  Giovanni D'Arena; Giovanni Rossi; Luca Laurenti; Teodora Statuto; Fiorella D'Auria; Luciana Valvano; Vittorio Simeon; Aldo Giudice; Idanna Innocenti; Vincenzo De Feo; Rosanna Filosa; Pellegrino Musto
Journal:  J Immunol Res       Date:  2016-07-14       Impact factor: 4.818

3.  Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients.

Authors:  Laurens E Franssen; Inger S Nijhof; Chad C Bjorklund; Hsiling Chiu; Ruud Doorn; Jeroen van Velzen; Maarten Emmelot; Berris van Kessel; Mark-David Levin; Gerard M J Bos; Annemiek Broijl; Saskia K Klein; Harry R Koene; Andries C Bloem; Aart Beeker; Laura M Faber; Ellen van der Spek; Reinier Raymakers; Pieter Sonneveld; Sonja Zweegman; Henk M Lokhorst; Anjan Thakurta; Xiaozhong Qian; Tuna Mutis; Niels W C J van de Donk
Journal:  Oncotarget       Date:  2018-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.